(+-)-5-deoxovariecolin - Compound Card

(+-)-5-deoxovariecolin

Select a section from the left sidebar

(+-)-5-deoxovariecolin

Structure
Zoomed Structure
  • Family: Fungi - Trichocomaceae
  • Kingdom: Fungi
  • Class: Terpenoid
    • Subclass: Sesterterpenoid
Canonical Smiles O=CC1=CC[C@@H]2[C@H]3[C@@H](CC[C@]3(C)CC[C@]2(C[C@H]2[C@@H]1CC[C@H]2C)C)C(=C)C
InChI InChI=1S/C25H38O/c1-16(2)19-10-11-24(4)12-13-25(5)14-21-17(3)6-8-20(21)18(15-26)7-9-22(25)23(19)24/h7,15,17,19-23H,1,6,8-14H2,2-5H3/t17-,19+,20-,21-,22-,23-,24-,25+/m1/s1
InChIKey JTDXOHMYFSPPKT-YJJWGBSOSA-N
Formula C25H38O
HBA 1
HBD 0
MW 354.58
Rotatable Bonds 2
TPSA 17.07
LogP 6.59
Number Rings 4
Number Aromatic Rings 0
Heavy Atom Count 26
Formal Charge 0
Fraction CSP3 0.8
Exact Mass 354.29
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Aspergillus aegyptiacus Trichocomaceae Fungi 5052

Showing of synonyms

  • Ibrahim S, Mohamed G, et al. (2015). Aegyptolidines A and B: New pyrrolidine alkaloids from the fungus Aspergillus aegyptiacus. Phytochemistry Letters,2015,12,90–93. [View]

No compound-protein relationship available.

Structure

SMILES: C1CCC(C12)CCC3C2CC=CC4C(C3)CCC4

Level: 0

Mol. Weight: 354.58 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.93
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.44
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.14

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
1.33
Plasma Protein Binding
66.44
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
9.6
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.85
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.32
Liver Injury II
Toxic
hERG Blockers
Toxic
Daphnia Maga
6.68
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Toxic
NR-ER
Toxic
NR-ER-LBD
Toxic
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-3.71
Rat (Acute)
4.05
Rat (Chronic Oral)
1.42
Fathead Minnow
3.94
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
412.66
Hydration Free Energy
-2.37
Log(D) at pH=7.4
6.19
Log(P)
7.18
Log S
-6.09
Log(Vapor Pressure)
-6.39
Melting Point
120.81
pKa Acid
9.83
pKa Basic
7.09
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 2 0.7135
Soluble acetylcholine receptor Q8WSF8 Q8WSF8_APLCA Aplysia californica 3 0.7091

Download SDF